The percent of tumor cellspositive for MMP-2 expression was significantly decreased in the INF-αgroup compared with the controls, and the MMP-2 levels in the combined therapygroup were further significantly reduced compared to the IFN-α, control,and IL-24 groups (Figure 8, Table 1). The gene discussed is IFNA17; the disease is neoplasm.